| Literature DB >> 36246270 |
Luis Gafeira Gonçalves1, Susana Santos1, Laidson Paes Gomes1, Jean Armengaud2, Maria Miragaia3, Ana Varela Coelho1.
Abstract
Staphylococcus epidermidis is one of the most common bacteria of the human skin microbiota. Despite its role as a commensal, S. epidermidis has emerged as an opportunistic pathogen, associated with 80% of medical devices related infections. Moreover, these bacteria are extremely difficult to treat due to their ability to form biofilms and accumulate resistance to almost all classes of antimicrobials. Thus new preventive and therapeutic strategies are urgently needed. However, the molecular mechanisms associated with S. epidermidis colonisation and disease are still poorly understood. A deeper understanding of the metabolic and cellular processes associated with response to environmental factors characteristic of SE ecological niches in health and disease might provide new clues on colonisation and disease processes. Here we studied the impact of pH conditions, mimicking the skin pH (5.5) and blood pH (7.4), in a S. epidermidis commensal strain by means of next-generation proteomics and 1H NMR-based metabolomics. Moreover, we evaluated the metabolic changes occurring during a sudden pH change, simulating the skin barrier break produced by a catheter. We found that exposure of S. epidermidis to skin pH induced oxidative phosphorylation and biosynthesis of peptidoglycan, lipoteichoic acids and betaine. In contrast, at blood pH, the bacterial assimilation of monosaccharides and its oxidation by glycolysis and fermentation was promoted. Additionally, several proteins related to virulence and immune evasion, namely extracellular proteases and membrane iron transporters were more abundant at blood pH. In the situation of an abrupt skin-to-blood pH shift we observed the decrease in the osmolyte betaine and changes in the levels of several metabolites and proteins involved in cellular redoxl homeostasis. Our results suggest that at the skin pH S. epidermidis cells are metabolically more active and adhesion is promoted, while at blood pH, metabolism is tuned down and cells have a more virulent profile. pH increase during commensal-to-pathogen conversion appears to be a critical environmental signal to the remodelling of the S. epidermidis metabolism toward a more pathogenic state. Targeting S. epidermidis proteins induced by pH 7.4 and promoting the acidification of the medical device surface or surrounding environment might be new strategies to treat and prevent S. epidermidis infections.Entities:
Keywords: Staphylococcus epidermidis; colonization; infection; metabolomics; pH adaptation; proteomics
Year: 2022 PMID: 36246270 PMCID: PMC9554481 DOI: 10.3389/fmicb.2022.1000737
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
FIGURE 1Scheme of the workflow followed. Cells from –80°C glycerol stocks were streaked in Tryptic Soy agar media (TSA) and a single colony was picked to inoculate a new TSA plate. From the plate a single colony was collected to prepare a pre-inoculum in TS broth medium with adjusted pH (pH 5.5 and 7.4) and incubated overnight at 37°C and 225 rpm. The inoculum at pH 5.5 was used for the cultures grown at 5.5 (N55) and 7.4 (N57), and the inoculum at pH 7.4 for the culture at the same pH (N77). The cells were harvested at mid-exponential phase. For proteomics the proteins were extracted from 4 biological replicates/experimental condition and analysed by nanoLC-MS/MS. Identified proteins (MASCOT) were quantified by spectral counts. Differential abundant proteins between experimental conditions were submitted to functional clustering analysis (STRINGdb). Metabolites from eight replicates/experimental condition were extracted, after metabolic quenching and biomass normalisation. Metabolites were assigned in 1H-NMR spectra acquired in an 800 MHz spectrometer (ChenomxNMRsuite). Their determined concentrations were used for pathway analysis (MetaboAnalyst).
FIGURE 2Volcano plots and Venn diagram of protein abundance differences between conditions. (A–C) Volcano plots of the proteins differentially abundant between each pair of experimental conditions (FC > 1.5, p-value < 0.05). Spots representing proteins with increased abundances in N55, N57 and N77 are coloured in red, yellow and green, respectively. (A) N55 vs N77; (B) N55 vs N57; and (C) N57 vs N77. (D) Venn diagram showing the number of proteins that are differentially abundant in the several comparisons of experimental conditions (N55 vs N77, N55 vs N57 and N57 vs N77).
FIGURE 3Hierarchical clustering of differentially abundant proteins. In green, red and yellow are identified the columns for the replicates of each experimental condition, respectively N55, N77, and N57. In the heatmap, red and blue correspond to higher and lower abundant proteins, respectively. The tree in the x axis represents the similarity among experimental conditions regarding abundance of proteins and in the y axis the proteome similarities. Proteins having increased levels in common between conditions N55 and N57 and conditions N57 and N77 are evidenced in black and purple rectangles, respectively.
FIGURE 4STRING network of differentially abundant proteins between N55 and N77 conditions. Proteins increased (A) and decreased (B) in condition N55 when compared with N77. (A) Proteins associated with glycerolipid metabolism are represented as red nodes. Blue, yellow and green shadowed ellipsis highlight proteins involved in folate and betaine biosynthesis and phosphate metabolism. (B) Proteins associated to purine and nucleotide metabolism are represented as red, purple, green and yellow nodes, while those associated with the biosynthesis of secondary metabolites are represented as pink nodes, including proteins involved in glycolysis/gluconeogenesis/pyruvate metabolism, oxidative phosphorylation, acetoin catabolism arginine and proline metabolism circled by blue, orange, red and green open ellipsis. The other clusters highlighted with dashed black, brown, yellow and magenta ellipsis are the phosphoenolpyruvate:sugar phosphotransferase system (PTS), membrane transporters, extracellular proteases and the SaeRS two-component signal transduction system (TCS).
Identified metabolites from S epidermidis 19N strain intracellular extract by 1H-NMR with respective levels in each experimental condition.
| Metabolites | N55 | N57 | N77 | N55/N77 | N55/N57 | N57/N77 | |||
| Mean | SD | Mean | SD | Mean | SD | Fold | Fold | Fold | |
| Acetate | 60.7 | 9.1 | 59.0 | 13.0 | 134.3 | 28.6 | 0.5 | 1.0 | 0.4 |
| Adenine | 11.1 | 7.0 | 8.3 | 4.2 | 15.4 | 5.8 | 0.7 | 1.3 | 0.5 |
| Alanine | 44.6 | 19.3 | 27.2 | 13.9 | 51.4 | 19.6 | 0.9 | 1.6 | 0.5 |
| Asparagine | 32.7 | 15.9 | 74.1 | 36.7 | 93.5 | 16.6 | 0.4 | 0.4 | 0.8 |
| Aspartate | 142.5 | 25.0 | 220.0 | 41.4 | 434.3 | 69.2 | 0.3 | 0.6 | 0.5 |
| Betaine | 1326.8 | 171.8 | 402.5 | 237.3 | 1254.2 | 149.8 | 1.1 | 3.3 | 0.3 |
| Choline | 32.0 | 7.6 | 4.5 | 1.4 | 15.2 | 1.5 | 2.1 | 7.0 | 0.3 |
| Cystathionine | 8.3 | 2.1 | 25.9 | 9.5 | 27.3 | 2.8 | 0.3 | 0.3 | 0.9 |
| Cytidine monophosphate | 17.6 | 12.2 | 12.3 | 9.7 | 26.9 | 8.0 | 0.7 | 1.4 | 0.5 |
| Glutamate | 807.3 | 99.7 | 442.3 | 125.3 | 651.0 | 43.4 | 1.2 | 1.8 | 0.7 |
| Glycine | 3.7 | 3.2 | 21.3 | 34.8 | 2.4 | 3.0 | 1.5 | 0.2 | 8.9 |
| Guanosine | 5.5 | 2.2 | 4.0 | 3.5 | 6.2 | 1.9 | 0.9 | 1.4 | 0.6 |
| Histidine | 4.2 | 1.4 | 3.6 | 0.5 | 5.4 | 1.0 | 0.8 | 1.2 | 0.7 |
| Isoleucine | 3.2 | 1.4 | 3.8 | 1.6 | 6.1 | 0.8 | 0.5 | 0.8 | 0.6 |
| Isovalerate | 3.4 | 2.2 | 1.4 | 0.9 | 4.1 | 0.9 | 0.8 | 2.5 | 0.3 |
| Lactate | 19.6 | 12.2 | 16.5 | 6.7 | 61.4 | 18.3 | 0.3 | 1.2 | 0.3 |
| Leucine | 16.8 | 4.4 | 16.1 | 7.0 | 25.4 | 5.0 | 0.7 | 1.0 | 0.6 |
| Lysine | 20.9 | 8.2 | 16.3 | 4.0 | 25.4 | 5.3 | 0.8 | 1.3 | 0.6 |
| NADP+ | 2.2 | 0.4 | 3.7 | 1.6 | 2.6 | 0.4 | 0.8 | 0.6 | 1.4 |
| Phenylalanine | 9.3 | 1.3 | 9.0 | 2.5 | 13.2 | 0.8 | 0.7 | 1.0 | 0.7 |
| Phosphoenolpyruvic acid | 11.2 | 2.4 | 18.0 | 7.0 | 10.7 | 5.0 | 1.1 | 0.6 | 1.7 |
| sn-Glycero-3-phosphocholine | 112.6 | 24.3 | 26.2 | 12.8 | 31.3 | 3.3 | 3.6 | 4.3 | 0.8 |
| Succinate | 18.6 | 8.2 | 10.6 | 2.9 | 18.5 | 2.6 | 1.0 | 1.8 | 0.6 |
| Tyrosine | 1.5 | 0.6 | 1.3 | 0.5 | 2.7 | 0.7 | 0.5 | 1.1 | 0.5 |
| Uracil | 9.3 | 7.6 | 3.7 | 3.6 | 11.1 | 3.0 | 0.8 | 2.5 | 0.3 |
| Valine | 7.3 | 0.9 | 6.0 | 2.4 | 10.5 | 1.4 | 0.7 | 1.2 | 0.6 |
| β-Alanine | 9.8 | 4.5 | 6.3 | 2.8 | 11.2 | 4.1 | 0.9 | 1.5 | 0.6 |
| 2-Hydroxyisobutyrate | 2.5 | 1.6 | 1.2 | 0.5 | 2.0 | 0.7 | 1.3 | 2.0 | 0.6 |
| 3-Hydroxyisovalerate | 6.7 | 4.6 | 4.7 | 0.9 | 4.8 | 3.5 | 1.4 | 1.4 | 1.0 |
| Adenosine | 24.4 | 10.8 | 19.0 | 13.3 | 29.7 | 12.0 | 0.8 | 1.3 | 0.6 |
| AMP | 5.7 | 1.7 | 6.8 | 5.0 | 7.5 | 5.1 | 0.8 | 0.8 | 0.9 |
| Arabinose | 17.3 | 4.5 | 13.5 | 7.1 | 16.4 | 4.7 | 1.1 | 1.3 | 0.8 |
| Coenzyme A | 5.5 | 1.9 | 12.1 | 6.7 | 11.9 | 9.1 | 0.5 | 0.5 | 1.0 |
| Formate | 94.8 | 65.7 | 36.5 | 21.0 | 67.2 | 54.8 | 1.4 | 2.6 | 0.5 |
| Glucose | 11.3 | 9.6 | 68.0 | 108.4 | 2.7 | 1.1 | 4.3 | 0.2 | 25.6 |
| Glutamine | 80.1 | 55.4 | 37.6 | 17.0 | 62.1 | 17.7 | 1.3 | 2.1 | 0.6 |
| NAD+ | 15.8 | 2.2 | 18.0 | 3.0 | 15.3 | 1.1 | 1.0 | 0.9 | 1.2 |
| Nicotinate | 2.1 | 1.0 | 1.1 | 0.4 | 1.6 | 0.4 | 1.3 | 1.9 | 0.7 |
| Sucrose | 7.0 | 10.3 | 84.5 | 75.6 | 5.5 | 7.1 | 1.3 | 0.1 | 15.3 |
| Threonine | 11.5 | 7.1 | 8.9 | 5.5 | 7.7 | 1.1 | 1.5 | 1.3 | 1.2 |
| Tryptophan | 1.4 | 0.5 | 2.0 | 0.6 | 2.3 | 1.1 | 0.6 | 0.7 | 0.9 |
| UMP | 5.9 | 3.8 | 5.2 | 3.2 | 8.3 | 3.4 | 0.7 | 1.1 | 0.6 |
| Uridine | 5.7 | 3.2 | 5.1 | 3.3 | 6.4 | 4.1 | 0.9 | 1.1 | 0.8 |
In the first (white background) and second section (grey background) are identified, the metabolites with levels significantly different (p-value ≤ 0.05), at least in one comparison, test, respectively. The fold change and p-value for each comparison in study are shown in the last 3 columns. and the non-differential by non-parametric Wilcoxon. *p-value ≤ 0.05; **p-value ≤ 0.01; ***p-value ≤ 0.001.
FIGURE 5PLS-DA model based on metabolites concentrations for the three pH conditions. (A) PLS-DA scores plot of first and second component, showing the discrimination between the 3 experimental conditions, N55 (green) N57 (yellow), and N77 (red) (with 5 components: R2 = 0.97 and Q2 = 0.92) using the metabolites levels. Metabolites that most contribute for the separation of the groups based on its VIP scores (>1) for (B) the first component and, (C) the second component; the colour scale presents the metabolite relative levels among the three experimental conditions.
FIGURE 6Metabolic pathways altered between the conditions based on metabolite concentrations. Pathway Analysis using the metabolite concentrations, performed in Metaboanalyst, of pairwise comparison among the 3 conditions: (A) N55 vs N77, (B) N55 vs N57, and (C) N57 vs N77; using Staphylococcus aureus N315 as a pathway library reference. Pathways named here obey the criteria of negative logarithm of p-value higher than 10 (y axis) and a pathway impact > 0, or pathway impact > 0.5 (x axis). Circle size is proportional to the pathway impact value and the colour to the -log(p) value, increasing from white to red.
Functional analysis of differentially abundant proteins between N55 and N77 conditions.
| Increased at pH 5.5 | ||
|
|
|
|
|
| ||
|
| ||
| Glycerate kinase | SERP0409 | garK |
| Aldehyde dehydrogenase | SERP1729/2084 | aldA |
| Glycerol dehydrogenase | SERP2346 | gldA |
| Dihydroxyacetone kinase | SERP2344/5 | |
| Triacylglycerol lipase | SERP2388 | geh-1 |
| Processive diacylglycerol beta-glucosyltransferase | SERP0606 | ypfP |
|
| ||
| Lactaldehyde dehydrogenase | SERP2080 | |
| Alcohol dehydrogenase, zinc-containing | SERP1785/6 | |
| Pyruvate oxidase | SERP2115 | |
| Catalase | SERP0903 | katA |
| Glutathione peroxidase | SERP0872 | gpxA-1 |
|
| ||
| Polyphosphate kinase | SERP2047 | ppk |
| Exopolyphosphatase | SERP2046 | |
|
| ||
| Oxygen-dependent choline dehydrogenase | SERP2176 | betA |
| Betaine aldehyde dehydrogenase | SERP2177 | betB |
|
| ||
| 2-Amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | SERP0155 | folK |
| Dihydropteroate synthase | SERP0153 | folP |
| GTP cyclohydrolase 1 | folE | |
|
| ||
| Glutamate synthase | SERP0109 | gltB |
| Formimidoylglutamase | SERP1919 | hutG |
|
| ||
| N-acetylmuramoyl-L-alanine amidase | SERP2263 | |
| Essential cell division protein | SERP0745 | ftsL |
| Two-component system WalK/WalR, regulator of histidine kinase | SERP2531 | YycI |
| ClpXP adapter protein | SERP0581 | SpxH |
|
| ||
| Aminoacyltransferase FemA | femA | |
|
| ||
| Drug resistance transporter | SERP1944 | |
| Drug transporter | SERP1945 | |
|
| ||
|
| ||
|
|
|
|
|
| ||
|
| ||
| Xanthine phosphoribosyltransferase | SERP0067 | xpt |
| Adenylate kinase | SERP1810 | adk |
| N5-carboxyaminoimidazole ribonucleotide synthase | SERP0650 | purK |
| Phosphoribosylformylglycinamidine synthase subunit PurL | SERP0654 | purL |
| Phosphoribosylformylglycinamidine cyclo-ligase | SERP0656 | purM |
| Phosphoribosylaminoimidazole-succinocarboxamide synthase | SERP0651 | purC |
| Phosphoribosylamine-glycine ligase | SERP0659 | purD |
| Phosphoribosylformylglycinamidine synthase | SERP0653 | purQ |
| Amidophosphoribosyltransferase | SERP0655 | purF |
|
| ||
| Glyceraldehyde-3-phosphate dehydrogenase | SERP1250 | gapA-2 |
| Fructose-bisphosphate aldolase | SERP1732 | fbaA |
| Pyruvate, phosphate dikinase | SERP1129 | ppdK |
| Pyruvate, water dikinase | SERP2169 | |
| Phosphoenolpyruvate carboxykinase | SERP1353 | pckA |
| Alcohol dehydrogenase | SERP0257 | adh |
| Acetate kinase | SERP1275 | ackA |
| Pyruvate formate lyase activating enzyme | SERP2365 | pflA |
| Formate acetyltransferase | SERP2366 | pflB |
| Dihydrolipoyl dehydrogenase | SERP2327 | |
| Dihydrolipoamide acetyltransferase | SERP2324 | |
|
| ||
| Cytochrome aa3-600 menaquinol oxidase subunit ii | SERP0646 | qoxB |
| Cytochrome aa3-600 menaquinol oxidase subunit iii | SERP0644 | qoxC |
| Succinate dehydrogenase / fumarate reductase, cytochrome b subunit | SERP0730 | sdhC |
| NADH:flavin oxidoreductase/fumarate reductase, flavoprotein subunit | SERP2381 | |
|
| ||
| Acetoin(diacetyl) reductase | SERP2257 | budC |
| Diacetyl reductase [(S)-acetoin forming] | SERP2379 | butA |
| Acetoin dehydrogenase | SERP2325 | acoA |
| Acetoin dehydrogenase | SERP2326 | acoB |
| Acetyl-CoA C-acetyltransferase | SERP0220 | vraB |
|
| ||
| Pyrroline-5-carboxylate reductase | SERP1065 | proC |
| Proline dehydrogenase | SERP1324 | putA |
| Nitric oxide synthase oxygenase | SERP1451 | |
| Ornithine carbamoyltransferase; | SERP2351 | arcB-2 |
| Carbamate kinase | SERP2352 | arcC |
| Delta-1-pyrroline-5-carboxylate dehydrogenase | SERP2128 | rocA |
|
| ||
| Fructose-specific IIABC components | SERP2260 | |
| Sucrose-specific IIBC components | SERP1900/68 | |
| Glucose-specific EIICBA component | SERP2114 | ptsG |
| 6-Phospho-beta-galactosidase | SERP1789 | lacG |
| Tagatose 1,6-diphosphate aldolase | SERP1792 | lacD |
|
| ||
| Multidrug resistance efflux pump | SERP1767 | SepA |
| Flotillin-like protein | SERP1140 | FloA |
| RND family efflux transporter | SERP0014 | |
| ABC transporter, substrate-binding protein | SERP0290 | ArsC1 |
| Transferrin receptor | SERP0949/403 | |
| Iron compound ABC transporter, ATP-binding protein | SERP0402 | |
| Hemin import ATP-binding protein | SERP0015 | HrtA |
| Hemin transport system permease protein | SERP0016 | HrtB |
| Iron transporter | SERP1139 | |
| Siderophore synthetase | SERP1779 | |
| Staphyloferrin B biosynthesis | SERP1781 | |
|
| ||
| Glutamyl endopeptidase | SspA | |
| Staphopain A Extracellular cysteine protease | sspB | |
| SdrG protein | SERP0207 | SdrG |
|
| ||
| Transcriptional regulator, AraC family | SERP1972 | |
| Two Component Signal Transduction System PhoPR, Sensory box histidine kinase | SERP1255 | phoR |
| Two Component Signal Transduction System SaeRS, Response regulator | SERP0365 | saeR |
| Staphylococcal Accessory Regulator family | SERP1849/76/79 | SarR/Z/V |
|
| ||
| NADPH-dependent 7-cyano-7-deazaguanine reductase | SERP0394 | queF |
| Queuine trna-ribosyltransferase | SERP1203 | tgt |
| Epoxyqueuosine reductase QueH | SERP2147 | queH |
| tRNA (guanine-N(1)-)-methyltransferase | SERP0806 | trmD |
FIGURE 7Metabolic pathways altered between N55 vs N77 based on the proteomic and metabolomic data. Reconstruction of the principal metabolic pathways that changed in S. epidermidis 19N when growth at blood pH (N77) when compared with skin pH (N55). Names of metabolites and enzymes increased in N77 are in red, while those increased in N55 are in green. Metabolites determined in the study but that do not show significant differences are in black, while metabolites undetected are in grey. Full arrows represent reactions, dashed arrows represent connections with other pathways or hidden reactions.